DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Neuronal SignalingNeuronal Signaling
  5. /MAOMAO
  6. /IndantadolIndantadol
Chemical structure of CAS 202844-10-8

Indantadol

CAS No.202844-10-8
MDL No.N/A
MFC11H14N2O
MW190.24
InChI KeyMNLULKBKWKTZPE-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.202844-10-8
Product NameIndantadol
Heavy Atom Count14Rotatable Bond Count3
Atom Stereo Count0Bond Stereo Count0
HBA2HBD2
TPSA55.120 ŲCharge0
Exact Mass190.11061Complexity323.90
pKa7.130XLogP0.229

Related Articles

Studies related to this compound and its mechanism of action

CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats.

European journal of pharmacology • Vol. 519, Issue 3 • 2005
PMID: 16125167DOI: 10.1016/j.ejphar.2005.07.004

Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects.

British journal of clinical pharmacology • Vol. 59, Issue 4 • 2005
PMID: 15801935PMC: PMC1884805DOI: 10.1111/j.1365-2125.2005.02338.x

Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects.

The Journal of pharmacology and experimental therapeutics • Vol. 313, Issue 2 • 2005
PMID: 15671203DOI: 10.1124/jpet.104.080457

CHF 3381.

Drugs in R&D • Vol. 5, Issue 1 • 2004
PMID: 14725488DOI: 10.2165/00126839-200405010-00005

Documentation

Similar Products

  • 2-Indancarboxylic Acid

    CAS No.25177-85-9

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact